Home » Media

Media

International Program Spotlights the BRICs at the 2013 BIO International Convention
With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities...
Farmers Increasingly Favor Biotech Crops
The ISAAA report, Global Status of Commercialized Biotech/GM Crops: 2012, says a record 17.3 million farmers in 28 countries are growing biotech crops on 420...

Press Releases

BIO Praises U.S. Senate for Passing the Pandemic and All-Hazards Preparedness Reauthorization Act
Feb 28 2013
WASHINGTON, DC – February 28, 2013 –The Biotechnology Industry Organization (BIO) lauds the Senate for passing H.R. 307, the Pandemic and All-...
BIO Praises U.S. Senate for Passing the Pandemic and All-Hazards Preparedness Reauthorization Act
Feb 28 2013
WASHINGTON, DC – February 28, 2013 –The Biotechnology Industry Organization (BIO) lauds the Senate for passing H.R. 307, the Pandemic and All-...
2013 BIO International Convention to Host Orphan Disease Forum
Feb 28 2013
Washington, DC (February 28, 2013) –The international orphan drug marketplace is expected to grow some 30 percent by 2014, fueled by the entrance of...
BIO Welcomes EPA Final Rule on New Advanced and Cellulosic Biofuels
Feb 26 2013
On Friday, the U.S. Environmental Protection Agency issued long-awaited approval for new feedstocks and biofuel processes under the Renewable Fuel Standard....
BIO World Congress to Address Industrial Biotech’s Role in Building a Biobased Economy
Feb 21 2013
BIO announces plenary session program for 2013 World Congress   The Biotechnology Industry Organization (BIO) announced its plenary session...
Farmers Increasingly Favor Biotech Crops
Feb 20 2013
Adoption of agricultural biotechnology increased six percent over past year as developing countries play leading role Farmers around the world continue to...
FDA Delay of Salmon Approval is a Blow to Science and Business
Feb 13 2013
  Now is not the time to gut job-creating investments in science and innovation The U.S. Food and Drug Administration (FDA) announced today that...
International Program Spotlights the BRICs at the 2013 BIO International Convention
Feb 13 2013
Washington, DC (February 13, 2013) – With one-third of all attendees international, the 2013 BIO International Convention will host a wide...
Innovation and The Supreme Court: Two Cases to Watch
Feb 11 2013
  WHAT: An inside look at two cases facing the Supreme Court of the United States: Bowman v. Monsantoand Molecular Pathology v. Myriad...
BIO President & CEO Greenwood Restates Call to Arms for Renewable Fuels
Feb 6 2013
Contrary to the assertions of the oil refiners, advanced biofuels are now a reality, BIO President & CEO Jim Greenwood said today in remarks on the...


Biotechnology News

Idera Announces Presentation at AAD Annual Meeting Demonstrating Toll-like Receptor Antagonists Normalize Expression of Inflammatory Genes in Psoriasis Model
March 2, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera presented new data showing that its selective Toll-like receptor antagonists normalized the gene expression of important cytokines...

Oral Apremilast Achieves Statistical Significance for the Primary Endpoint of PASI-75 in the First Phase III Study (ESTEEM 1) in Patients with Psoriasis
March 2, 2013

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented the results from ESTEEM 1, the Company...

KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Study of ATX-101 in the Reduction of Unwanted Submental Fat (SMF) or “Double Chin”
March 2, 2013

MIAMI BEACH, Fla.--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced positive interim results from a Phase IIIb, multi-center, open-label...

‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says the Committee on Fair Drug Pricing (a.k.a. FAIR)
March 1, 2013

SAN FRANCISCO--(BUSINESS WIRE)--‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says Committee on Fair Drug Pricing (a.k.a. FAIR)-Coalition of...

Gilead Sciences to Present at the Cowen & Company 33rd Annual Health Care Conference on Monday, March 4
March 1, 2013

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Cowen and Company 33rd...